EUVIMEDEUVIMED entdecken
Kohortenstudie

Phosphatidylserine-dependent antiprothrombin antibodies as a key predictor for systemic lupus erythematosus in patients with primary antiphospholipid syndrome: A retrospective longitudinal cohort study

Jiang Wei, Yuichiro Fujieda iD, Yusuke Fujita, Yusuke Ogata, Ryo Hisada, Michihito Kono iD, Olga Amengual, Masaru Kato iD, Tatsuya Atsumi

Modern Rheumatology · 2025

DOI: 10.1093/mr/roae073 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Jiang Wei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Antiphospholipid Syndrome, Phosphatidylserines, Antibodies, Antiphospholipid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Primary antiphospholipid syndrome (PAPS) is an autoimmune disorder characterized by thrombosis and pregnancy morbidity. Although PAPS is distinct from systemic lupus erythematosus (SLE), the two conditions share clinical features and susceptibility genes. Progression from PAPS to SLE is well recognized. However, risk factors for this transition are poorly understood. We aimed to identify predictors of progression to SLE in patients with PAPS.

Methods

A longitudinal single-centre study was conducted at Hokkaido University Hospital from 1990 to 2021. Baseline characteristics, including clinical features, laboratory data, and antiphospholipid antibody profiles, were compared between patients who progressed to SLE (SLE group) and those who did not (non-SLE group).

Results

Among 64 patients diagnosed with PAPS at baseline, nine (13.8%) progressed to SLE over a mean follow-up duration of 9 years (incidence rate, 1.61 per 100 person-years). At the time of the diagnosis of PAPS, the SLE group had a higher prevalence of phosphatidylserine-dependent antiprothrombin antibody (aPS/PT) and anti-dsDNA antibodies compared to the non-SLE group. Other clinical findings, autoantibody profiles, and serum complement levels were similar between the two groups. Multivariate Cox analysis showed that aPS/PT IgG was significantly associated with SLE development (hazard ratio: 10.3, 95% confidence interval: 1.13–92.6, P = .04). Conclusions aPS/PT IgG may be a predictive factor for new-onset SLE in patients with PAPS, suggesting its utility in guiding risk stratification and monitoring strategies for these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicAntiphospholipid SyndromePhosphatidylserinesAntibodies, AntiphospholipidAutoantibodiesProthrombinHumansFemaleRetrospective StudiesLongitudinal StudiesAdultMiddle AgedMaleDisease Progression

Stichwörter der Autor:innen

Primary antiphospholipid syndrome (PAPS)antiphospholipid antibodieslongitudinal studyphosphatidylserine-dependent antiprothrombin antibody (aPS/PT)systemic lupus erythematosus (SLE)

Substanzen

PhosphatidylserinesAntibodies, AntiphospholipidAutoantibodiesProthrombin

Autor:innen und Institutionen

  • Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Takikawa Municipal Hospital, Takikawa, Japan.

ORCID-Profile: Yuichiro Fujieda, Michihito Kono, Masaru Kato

Zitieren

APA

Wei, J., Fujieda, Y., Fujita, Y., Ogata, Y., Hisada, R., Kono, M., Amengual, O., Kato, M., & Atsumi, T. (2025). Phosphatidylserine-dependent antiprothrombin antibodies as a key predictor for systemic lupus erythematosus in patients with primary antiphospholipid syndrome: A retrospective longitudinal cohort study. Modern Rheumatology. https://doi.org/10.1093/mr/roae073

Vancouver

Wei J, Fujieda Y, Fujita Y, Ogata Y, Hisada R, Kono M, et al. Phosphatidylserine-dependent antiprothrombin antibodies as a key predictor for systemic lupus erythematosus in patients with primary antiphospholipid syndrome: A retrospective longitudinal cohort study. Modern Rheumatology. 2025. doi:10.1093/mr/roae073

BibTeX
@article{Wei2025,
  author = {Wei, Jiang and Fujieda, Yuichiro and Fujita, Yusuke and Ogata, Yusuke and Hisada, Ryo and Kono, Michihito and Amengual, Olga and Kato, Masaru and Atsumi, Tatsuya},
  title = {Phosphatidylserine-dependent antiprothrombin antibodies as a key predictor for systemic lupus erythematosus in patients with primary antiphospholipid syndrome: A retrospective longitudinal cohort study},
  journal = {Modern Rheumatology},
  year = {2025},
  doi = {10.1093/mr/roae073}
}
Kostenlos starten →